Syria

The exemptions allow for face masks, diagnostics and oxygen tanks, among others, to be shipped to Iran, Syria and Venezuela without specific permission.

President Barack Obama plans to announce a substantial expansion to the US response to the Ebola outbreak in West Africa – which he has called a top national security priority for the US – declaring the administration will use a command-and-control approach, putting a US Army general in charge of 3,000 military personnel to combat the epidemic and humanitarian crisis, and is committing more than $800m to the effort.

In an effort to respond to the World Health Organization's call for a polio-free world, China has decided to shift to the use of safer injected, inactivated polio vaccines (IPVs) by 2018, marking a step away from the current oral polio vaccine (OPV), which has been widely administered in the country since the 1960's due to its low cost and high efficacy.

The continuing investigation into sarin nerve gas attacks in Syria demonstrates a colder but ultimately more rational approach to international relationships. Shamefully, it is more evidence-based than attacks from some parts of pharma on international intellectual property positions.

With a double bombing in Boston, a fertilizer plant explosion in Texas, a ricin-laced letter attack on Washington and flooding in Chicago and other areas of the Midwest, President Barack Obama called this past week "tough."

When Mohamed Bouazizi, a 26-year-old Tunisian fruit-and-vegetable seller, set himself alight almost two years ago, starting what has become known as The Arab Spring, few could have predicted that long-standing regimes would soon start toppling like dominoes.

[C#200000856:Generex] Biotechnologyhas submitted a marketing application in Syria for its oral insulin product, [C#200000856:Generex] Oral-lyn, and expects approval before the end of next year. [C#200000856:Generex]'s product uses its RapidMist device to deliver a liquid spray of insulin to the lining of the mouth. The product is available in Ecuador, and has been approved for sale in India. Phase III clinical trials are under way in the US and elsewhere.